abstract |
Disclosed is an oral tablet composition comprising lenalidomide, wherein the composition is in the form of a tablet with further improved convenience, handling, safety, and the like. Since the coating layer can separate the drug from the inside, there is no teratogenic lenalidomide drug in the coating layer. |